Our Team
digiM is a team of scientists developing the latest technologies in microstructure science and in silico prediction. We work closely with our partners to navigate the complexities of drug product development.
Leadership Team
Shawn Zhang, Ph.D.
Shawn is a co-founder and managing partner of DigiM. Shawn graduated from Rutgers University with a Ph.D. in Computational Physics and a minor in Computer Engineering. Before starting Boston-based DigiM, Shawn held senior positions at leading CAE software company Fluent (now Ansys) and leading electron microscopy company FEI (now ThermoFisher). Shawn is passionate about the combined power of imaging, AI, and computational physics. With hundreds of publications, patents, and software products, Shawn leads DigiM to becoming a trusted partner in microstructure science across multiple industries. Learn more about Shawn’s work in Google Scholar or LinkedIn.
Andrew Clark, Ph.D.
Leading a passionate team of application scientists, Andrew supports the execution of client programs and the development of new image-based technologies and characterizations within digiM. Andrew received his Ph.D. in Physics from Tufts with a focus on experimental polymer physics and solid-state characterization.
Aiden Zhu, Ph.D.
Aiden joined DigiM with 15+ years of experience in pharmaceutical industry. His research interests focus on a variety of imaging modalities from drug substance, drug products, medical devices, small animals, all the way to human patients. Prior to DigiM, Aiden managed the imaging lab at Mass General Hospital and Pfizer. Aiden has a Ph.D. in physics and a M.S. in computer science. He has over 30 publications in peer-reviewed journals and book chapters.
.jpeg)
Ronald Smith, Ph.D.
Phil Yawman
Transform Your Program with Microstructure Science
Get started with a drug product digital twin.
